How many institutions held TXMD - TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share in Q1 2026?

47 institutional investors reported TXMD - TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share for Q1 2026. Use the holders table for investor-level position and value details.

TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD)

Q: What does CUSIP 88338N206 represent in this 13F holders report?

CUSIP 88338N206 is the security identifier for TXMD - TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 88338N206

Q1 2026 13F Holders as of 31 Mar 2026

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 3,930,452
Total 13F value: $7,939,211
Share change: +520,174
SEC-reported price per share: $2.02
Number of holders: 47
Value change: +$1,050,571
Number of buys: 14
Number of sells: 12
Shares outstanding: 11,627,985

Security key

88338N206

Report period

Q1 2026

Institutions

Top holders

TXMD full security history Ownership snapshot Full 13F holder table TherapeuticsMD, Inc. SEC filings TherapeuticsMD, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of TXMD - TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Clearline Capital LP

Disclosed value leader

Rubric Capital Management LP

Comparable rows

15/15

Latest evidence

31 Dec 2025

13F 13D/G 3/4/5 Lead comparable stake: 5.5% 13D/G row: Clearline Capital LP Showing 1-6 of 15 holder rows.

Quick read

Clearline Capital LP leads the comparable SEC ownership view at 5.5%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Clearline Capital LP's linked filing trail.

Comparable ownership Top 5

Clearline Capital LP 5.5%

Rubric Capital Management LP 10%

VANGUARD GROUP INC 3.4%

Tejara Capital Ltd 3%

ADAR1 Capital Management, LLC 1.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Clearline Capital LP	13F 13D/G Company 13F 13D/G	5.5% from 13D/G	$1,035,412 635,222 shares	—	31 Dec 2025
Rubric Capital Management LP	3/4/5 13F Director, Other*, 10%+ Owner · Company 3/4/5 13F	10% from 13F	$6,718,950 2,946,908 shares	—	15 Nov 2023
VANGUARD GROUP INC	13F Company 13F	3.4%	$647,201 397,056 shares	—	31 Dec 2025
Tejara Capital Ltd	13F Company 13F	3%	$571,889 350,852 shares	—	31 Dec 2025
ADAR1 Capital Management, LLC	13F Company 13F	1.8%	$341,012 209,210 shares	—	31 Dec 2025
MORGAN STANLEY	13F Company 13F	1.1%	$210,624 129,217 shares	—	31 Dec 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

3,930,452

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q1 2026 Across Filers

Q1 2026 holders

Holder diff

Investor	Q1 2026 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q1 2026 value	Value change	Value Chg %